Author
Listed:
- Joshi M. Ramanjulu
(GlaxoSmithKline)
- G. Scott Pesiridis
(GlaxoSmithKline)
- Jingsong Yang
(GlaxoSmithKline)
- Nestor Concha
(GlaxoSmithKline)
- Robert Singhaus
(GlaxoSmithKline)
- Shu-Yun Zhang
(GlaxoSmithKline)
- Jean-Luc Tran
(GlaxoSmithKline)
- Patrick Moore
(GlaxoSmithKline)
- Stephanie Lehmann
(Cellzome, GlaxoSmithKline R&D)
- H. Christian Eberl
(Cellzome, GlaxoSmithKline R&D)
- Marcel Muelbaier
(Cellzome, GlaxoSmithKline R&D)
- Jessica L. Schneck
(GlaxoSmithKline)
- Jim Clemens
(GlaxoSmithKline)
- Michael Adam
(GlaxoSmithKline)
- John Mehlmann
(GlaxoSmithKline)
- Joseph Romano
(GlaxoSmithKline)
- Angel Morales
(GlaxoSmithKline)
- James Kang
(GlaxoSmithKline)
- Lara Leister
(GlaxoSmithKline)
- Todd L. Graybill
(GlaxoSmithKline)
- Adam K. Charnley
(GlaxoSmithKline)
- Guosen Ye
(GlaxoSmithKline)
- Neysa Nevins
(GlaxoSmithKline)
- Kamelia Behnia
(GlaxoSmithKline)
- Amaya I. Wolf
(GlaxoSmithKline)
- Viera Kasparcova
(GlaxoSmithKline)
- Kelvin Nurse
(GlaxoSmithKline)
- Liping Wang
(GlaxoSmithKline)
- Ana C. Puhl
(GlaxoSmithKline)
- Yue Li
(GlaxoSmithKline)
- Michael Klein
(GlaxoSmithKline)
- Christopher B. Hopson
(GlaxoSmithKline)
- Jeffrey Guss
(GlaxoSmithKline)
- Marcus Bantscheff
(Cellzome, GlaxoSmithKline R&D)
- Giovanna Bergamini
(Cellzome, GlaxoSmithKline R&D)
- Michael A. Reilly
(GlaxoSmithKline)
- Yiqian Lian
(GlaxoSmithKline)
- Kevin J. Duffy
(GlaxoSmithKline)
- Jerry Adams
(GlaxoSmithKline)
- Kevin P. Foley
(GlaxoSmithKline)
- Peter J. Gough
(GlaxoSmithKline)
- Robert W. Marquis
(GlaxoSmithKline)
- James Smothers
(GlaxoSmithKline)
- Axel Hoos
(GlaxoSmithKline)
- John Bertin
(GlaxoSmithKline)
Abstract
Change history: In this Letter, author Ana Puhl was inadvertently omitted; this error has been corrected online. An amendment to this paper has been published and can be accessed via a link at the top of the paper
Suggested Citation
Joshi M. Ramanjulu & G. Scott Pesiridis & Jingsong Yang & Nestor Concha & Robert Singhaus & Shu-Yun Zhang & Jean-Luc Tran & Patrick Moore & Stephanie Lehmann & H. Christian Eberl & Marcel Muelbaier & , 2019.
"Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activity,"
Nature, Nature, vol. 570(7761), pages 53-53, June.
Handle:
RePEc:nat:nature:v:570:y:2019:i:7761:d:10.1038_s41586-019-1265-5
DOI: 10.1038/s41586-019-1265-5
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:570:y:2019:i:7761:d:10.1038_s41586-019-1265-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.